[1]
A. A. Faruqui, “Can DPP-4 Enhibitors and SGLT-2 Inhibitors Pleotropic Effects be Extended to Treat Diabetic Nephropathy?”, J. Medicine, vol. 24, no. 1, pp. 43–49, Mar. 2023.